About Neurosynaptic
Neurosynaptic is a company based in Bengaluru (India) founded in 2002 by Rajeev Kumar and Sameer Subhash Sawarkar.. Neurosynaptic has raised $1.61 million across 6 funding rounds from investors including KOIS, HealthQuad and Axilor Ventures. The company has 30 employees as of March 31, 2024. Neurosynaptic operates in a competitive market with competitors including NuvoAir, MedTel Healthcare, WuXi Diagnostics, Coagulo and Zio Health, among others.
- Headquarter Bengaluru, India
- Employees 30 as on 31 Mar, 2024
- Founders Rajeev Kumar, Sameer Subhash Sawarkar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurosynaptic Communications Private Limited
- Date of Incorporation 20 Sep, 2002
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$1.3 M (USD)38.92as on Mar 31, 2023
-
Net Profit
$50.26 K (USD)109.61as on Mar 31, 2023
-
EBITDA
$304.82 K (USD)70.02as on Mar 31, 2023
-
Total Equity Funding
$1.61 M (USD)
in 6 rounds
-
Latest Funding Round
$118.8 K (USD), Series A
Sep 30, 2020
-
Investors
KOIS
& 58 more
-
Employee Count
30
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neurosynaptic
Neurosynaptic has successfully raised a total of $1.61M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $118.8 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $118,795
-
First Round
First Round
(24 Jul 2006)
- Investors Count 59
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series A - Neurosynaptic | Valuation | KOIS | |
| May, 2019 | Amount | Series A - Neurosynaptic | Valuation | Nagaraja Prakasam , Sunil Kant Munjal | |
| Sep, 2016 | Amount | Series A - Neurosynaptic | Valuation | HealthQuad |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neurosynaptic
Neurosynaptic has secured backing from 59 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include KOIS, HealthQuad and Axilor Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on acquisitions
|
Founded Year | Domain | Location | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Founded Year | Domain | Location | |
|
Angel investor network investing in early-stage startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurosynaptic
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neurosynaptic
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurosynaptic Comparisons
Competitors of Neurosynaptic
Neurosynaptic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, MedTel Healthcare, WuXi Diagnostics, Coagulo and Zio Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical decision support tools for respiratory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Remote patient monitoring software is developed for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Diagnostic solutions for disease identification are offered to healthcare providers.
|
|
| domain | founded_year | HQ Location |
Precision-medicine platform for blood coagulation disease diagnosis is offered.
|
|
| domain | founded_year | HQ Location |
Molecular-level home analysis and monitoring for personalized healthcare is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurosynaptic
Frequently Asked Questions about Neurosynaptic
When was Neurosynaptic founded?
Neurosynaptic was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Where is Neurosynaptic located?
Neurosynaptic is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Neurosynaptic?
Sameer Subhash Sawarkar is the current CEO of Neurosynaptic. They have also founded this company.
Is Neurosynaptic a funded company?
Neurosynaptic is a funded company, having raised a total of $1.61M across 6 funding rounds to date. The company's 1st funding round was a Series A of $951.05K, raised on Jul 24, 2006.
How many employees does Neurosynaptic have?
As of Mar 31, 2024, the latest employee count at Neurosynaptic is 30.
What is the annual revenue of Neurosynaptic?
Annual revenue of Neurosynaptic is $1.3M as on Mar 31, 2023.
What does Neurosynaptic do?
Neurosynaptic is a healthcare technology involved in the development of ICT-based products. The company developing a diagnostic kit - ReMeDi for medical data storage and access and comprising of products such as ECG, stethoscope, temperature measuring, oximeter, etc. The professional edition provides patient and doctor application software which is cloud-based and enables remote consultation. Its enterprise edition comprises of server application along with patient and doctor-client applications offering multiple features. The company claims that its flagship platform, ReMeDi has been deployed in 1600 operational health centers in several developing countries and reaches 50 million people.
Who are the top competitors of Neurosynaptic?
Neurosynaptic's top competitors include MedTel Healthcare, WuXi Diagnostics and NuvoAir.
Who are Neurosynaptic's investors?
Neurosynaptic has 59 investors. Key investors include KOIS, HealthQuad, Axilor Ventures, Ventureast, and e-Zest.
What is Neurosynaptic's valuation?
The valuation of Neurosynaptic is $3.73M as of Sep 2020.